Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Biomarkers for Gynecologic Cancer
- Status
- UNKNOWN
- Phase
- N/A
Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)
- Status
- COMPLETED
- Phase
- N/A
An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics
- Status
- COMPLETED
- Phase
- NA
Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility
- Status
- COMPLETED
- Phase
- NA
Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Photoacoustic Imaging of the Ovary
- Status
- TERMINATED
- Phase
- NA
Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass
- Status
- COMPLETED
- Phase
- N/A
Women's Activity and Lifestyle Study in Connecticut
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Ensuring Communication in Hospice by Oncology Study (ECHO)
- Status
- COMPLETED
- Phase
- NA
Blood Collection From People With Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2